Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Kidney Transplantation × Infliximab × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Melanoma 1 Lung Neoplasms 1 Kidney Transplantation 1 Carcinoma, Renal Cell 1

Interventions

Tacrolimus 1 Sirolimus 1 Infliximab 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02711202 2025-06-04

Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation

Institute for Clinical and Experimental Medicine

Phase NA Completed

20 enrolled 11 charts

Kidney Transplantation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡